Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options. | Explor Target Antitumor Ther | 2022 | 36338517 | PubTator, text mining | PubMed |
| Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling. | NPJ Precis Oncol | 2022 | 36333410 | PubTator, text mining | PubMed |
| Kinase Fusion-Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics. | Endocr Pathol | 2022 | 36308634 | PubTator, text mining | PubMed |
| Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study. | Int J Mol Sci | 2022 | 36293366 | PubTator, text mining | PubMed |
| FBN1 Splice-Altering Mutations in Marfan Syndrome: A Case Report and Literature Review. | Genes (Basel) | 2022 | 36292727 | PubTator, text mining | PubMed |
| An Electrochemical Immunosensor for the Determination of Procalcitonin Using the Gold-Graphene Interdigitated Electrode. | Biosensors (Basel) | 2022 | 36290909 | PubTator, text mining | PubMed |
| Phenotypic plasticity and genetic control in colorectal cancer evolution. | Nature | 2022 | 36289336 | PubTator, text mining | PubMed |
| The co-evolution of the genome and epigenome in colorectal cancer. | Nature | 2022 | 36289335 | PubTator, text mining | PubMed |
| Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies. | Front Pharmacol | 2022 | 36278239 | PubTator, text mining | PubMed |
| Emerging genetic biomarkers in lung adenocarcinoma. | SAGE Open Med | 2022 | 36277445 | PubTator, text mining | PubMed |
| Silencing of circCYP51A1 represses cell progression and glycolysis by regulating miR-490-3p/KLF12 axis in osteosarcoma under hypoxia. | J Bone Oncol | 2022 | 36276300 | PubTator, text mining | PubMed |
| TRIM family contribute to tumorigenesis, cancer development, and drug resistance. | Exp Hematol Oncol | 2022 | 36261847 | PubTator, text mining | PubMed |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2022 | 36243813 | PubTator, text mining | PubMed |
| Substrate-Dependent Regioselectivity: Pd/PTC Cooperatively Catalyzed Domino Heck/Allylation of Allenamides with α-Carbon of Carbonyl Compounds. | J Org Chem | 2022 | 36240155 | PubTator, text mining | PubMed |
| MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. | Cells | 2022 | 36231143 | PubTator, text mining | PubMed |
| Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives. | Cancers (Basel) | 2022 | 36230877 | PubTator, text mining | PubMed |
| FGFR2-CCDC6 fusion gene promotes the proliferation of Hucct-1 cells. | Cell Mol Biol (Noisy-le-grand) | 2022 | 36227665 | PubTator, text mining | PubMed |
| Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient. | Front Oncol | 2022 | 36226049 | PubTator, text mining | PubMed |
| Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis. | Mol Cancer | 2022 | 36217175 | PubTator, text mining | PubMed |
| A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples. | Front Mol Biosci | 2022 | 36213130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=20